Monthly GP Update: August 2026
Aug 12, 2026
July has come and gone, and we're already halfway through August - my, how time flies! By now, you should be seeing your Q2 Medicaid rebate invoices arriving, making this a good time to shift focus to the next round of Government Pricing deadlines and developments on the horizon.
Upcoming Government Pricing Deadlines
A few important dates are right around the corner:
August 17 – Q2 Quarterly NFAMP submissions due
Mid-August – Q2 Medicaid rebate invoices begin arriving
August 20 – TRICARE payments due
August 28 – Q2 PHS/340B pricing calculations due to HRSA (establishes Q4 340B ceiling prices)
August 31 – July AMP submissions due
September 15 – Q4 PHS/340B prices due to wholesalers and distributors
You can find a full list of upcoming deadlines, conferences, and other important dates on The Pricing Group's online Calendar. If you have questions about any upcoming reporting requirements or need assistance preparing for these deadlines, please don’t hesitate to reach out.
MDRP Summit
The Medicaid Drug Rebate Program (MDRP) Summit takes place in Chicago, October 5-7. With so much regulatory change in motion this year, the agenda is shaping up to be especially timely, bringing together regulators, manufacturers, and industry experts to discuss the latest developments in Medicaid and Government Pricing.
TPG will be exhibiting, and we look forward to connecting with colleagues and industry partners. Be sure to stop by our booth and meet the TPG team!
Registration is open, and code 26PRICINGGRP10 saves you 10%. We hope to see you there!
Government Pricing “Hot Topics”
A few key issues we’re watching closely:
PHS/340B
Contract pharmacy restrictions – Litigation and a growing number of state laws continue to shape manufacturers' ability to limit distribution through contract pharmacies.
340B rebate model – Manufacturers continue to push for a claims-based rebate model to reduce diversion and duplicate discounts. HRSA's initial pilot was vacated by a federal court, but discussion of alternative approaches continues.
Medicare Part D
The Administration announced that Part D premium stabilization subsidies will end after December 31, 2026. Current estimates suggest many beneficiaries could see premiums rise roughly $11–$20 per month starting in 2027. For manufacturers, the bigger impact will likely be continued downward pressure on net prices as plans seek additional rebates and price concessions to offset higher liability under the redesigned benefit.
2027 Physician Fee Schedule Proposed Rule
CMS published the 2027 Physician Fee Schedule Proposed Rule on July 16 which would require 340B covered entities to submit quarterly Medicare Part D claims data beginning in 2027. For manufacturers, this is a meaningful step toward the transparency they've been requesting — improving identification of 340B claims and helping prevent duplicate discounts under the IRA. It’s lengthy but worth reading the relevant sections. Comments are due September 14, 2026.
If you’d like to discuss how any of these developments may affect your organization, we’d be happy to take a closer look with you.
Disclaimer: This update is intended for general informational purposes only and is not tailored to the facts or circumstances of any specific company. It should not be construed as legal advice. Some topics discussed may not apply to your organization, and additional requirements not addressed here may be relevant. Please contact us if you'd like to discuss how any of these developments apply to your specific situation.